Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function (Q28195655)

https://api.crossref.org/works/10.3317/JRAAS.2003.005

23 December 2023

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

23 December 2023

author name string

Bo-qing Zhu

1

0 references

Kanu Chatterjee

5

0 references

William Grossman

6

0 references

Richard E. Sievers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692751

23 December 2023

Amanda E. M. Browne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692751

23 December 2023

Randall J. Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692751

23 December 2023

Joel S. Karliner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692751

23 December 2023

William W. Parmley

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692751

Journal of the Renin-Angiotensin-Aldosterone System

23 December 2023

language of work or name

English

0 references

publication date

March 2003

0 references

published in

0 references

volume

4

0 references

issue

1

0 references

page(s)

31-7

0 references

cites work

Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Aspirin inhibits platelet activity but does not attenuate experimental atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Role of AT1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Role of endogenous angiotensin II in the control of vasopressin secretion during hypovolemia and hypotension in conscious rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

A model of acute regional myocardial ischemia and reperfusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Is the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Infarct size is reduced and the frequency of non-Q-wave myocardial infarctions is increased in patients using aspirin at the onset of symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Recent aspirin use is associated with smaller myocardial infarct size and lower likelihood of Q-wave infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Aspirin improves endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Effects of low-dose aspirin on endothelial function in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus angiotensin-converting enzyme inhibitor therapy alone on readmission rates in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Update on the interaction between aspirin and angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.005

Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure

21 January 2018

2

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction

23 December 2023

3

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

The interaction of ACE inhibitors and aspirin in heart failure: torn between two lovers

23 December 2023

9

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

Aspirin enhances the benefits of late reperfusion on infarct shape. A possible mechanism of the beneficial effects of aspirin on survival after acute myocardial infarction

23 December 2023

17

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts

23 December 2023

18

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin

23 December 2023

22

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

Interaction between aspirin and angiotensin-converting enzyme inhibitors: real or imagined

23 December 2023

25

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not

23 December 2023

26

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?

23 December 2023

27

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan

23 December 2023

43

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

23 December 2023

44

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

Effect of losartan on human platelet activation

23 December 2023

45

1 reference

https://api.crossref.org/works/10.3317/JRAAS.2003.005

23 December 2023

Identifiers

0 references